Authors:
Saskena, S
Domanski, MJ
Benjamin, EJ
Camm, AJ
Ezekowitz, MD
Gersh, BJ
Jalife, J
Naccarelli, GV
Vlietstra, RE
Wyse, DG
Citation: S. Saskena et al., Report of the NASPE/NHLBI Round Table on future research directions in atrial fibrillation, J INTERV C, 5(3), 2001, pp. 345-364
Authors:
Huynh, TTT
Davies, MG
Thompson, MA
Ezekowitz, MD
Hagen, PO
Annex, BH
Citation: Ttt. Huynh et al., Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts, J VASC SURG, 33(2), 2001, pp. 400-407
Authors:
Saksena, S
Domanski, MJ
Benjamin, EJ
Camm, AJ
Ezekowitz, MD
Gersh, BJ
Jalife, J
Naccarelli, GV
Vlietstra, RE
Wyse, DG
Citation: S. Saksena et al., Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation, PACE, 24(9), 2001, pp. 1435-1451
Authors:
Domanski, MJ
Zipes, DP
Benditt, DG
Camm, AJ
Exner, DV
Ezekowitz, MD
Greene, HL
Lesh, MD
Miller, JM
Pratt, CM
Saksena, S
Scheinman, MM
Singh, BN
Tracy, CM
Waldo, AL
Citation: Mj. Domanski et al., Central clinical research issues in electrophysiology: Report of the NASPECommittee, PACE, 24(4), 2001, pp. 526-534
Authors:
Schwartz, GG
Olsson, AG
Ezekowitz, MD
Ganz, P
Oliver, MF
Waters, D
Zeiher, A
Chaitman, BR
Leslie, S
Stern, T
Citation: Gg. Schwartz et al., Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial, J AM MED A, 285(13), 2001, pp. 1711-1718
Authors:
Pu, Q
Wiel, E
Corseaux, D
Bordet, R
Azrin, MA
Ezekowitz, MD
Lund, N
Jude, B
Vallet, B
Citation: Q. Pu et al., Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endotheliumin Escherichia coli endotoxin-induced shock, CRIT CARE M, 29(6), 2001, pp. 1181-1188
Authors:
Klem, JA
Schaffer, JV
Crane, PD
Barrett, JA
Henry, GA
Canestri, L
Ezekowitz, MD
Citation: Ja. Klem et al., Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: A preliminary report, J NUCL CARD, 7(4), 2000, pp. 359-364
Citation: Dh. Jagasia et al., Clinical implication of antiembolic trials in atrial fibrillation and roleof transesophageal echocardiography in atrial fibrillation, CURR OPIN C, 15(1), 2000, pp. 58-63
Authors:
Corseaux, D
Meurice, T
Six, I
Rugeri, L
Ezekowitz, MD
Rouvier, P
Bordet, R
Bauters, C
Jude, B
Citation: D. Corseaux et al., Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall, CIRCULATION, 101(16), 2000, pp. 2000-2006
Citation: Cj. Howes et Md. Ezekowitz, Alternate-day dosing of aspirin in atrial fibrillation: A critical evaluation, AM HEART J, 138(1), 1999, pp. 13-13
Authors:
Annex, BH
Davies, MG
Fulton, GJ
Huynh, TTT
Channon, KM
Ezekowitz, MD
Hagen, PO
Citation: Bh. Annex et al., Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts, J SURG RES, 80(2), 1998, pp. 164-170